SENATE BILL REPORT

                                    SB 6192

             AS REPORTED BY COMMITTEE ON HEALTH & LONG-TERM CARE,

                               FEBRUARY 6, 1992

Brief Description:  Changing certain drug regulations.

SPONSORS: Senators West, Vognild, Sellar, Murray and L. Smith

SENATE COMMITTEE ON HEALTH & LONG‑TERM CARE

Majority Report:  That Substitute Senate Bill No. 6192 be substituted therefor, and the substitute bill do pass. 

      Signed by Senators West, Chairman; L. Smith, Vice Chairman; Amondson, M. Kreidler, Newhouse, Niemi, and Wojahn.

Staff:  Martin Lovinger (786‑7443)

Hearing Dates: February 5, 1992; February 6, 1992

BACKGROUND:

Under current law legend drugs and controlled substances are regulated under three different statutes, the Pharmacy Act (RCW 18.64), the Legend Drug Act (RCW 69.41), and the Controlled Substances Act (RCW 69.50).  The definitions under these three sections are not always uniform.  Nor are they always in alphabetical order, which makes reference to them difficult.

SUMMARY:

The definitions in the Pharmacy Act, the Legend Drug Act and the Controlled Substances Act are placed in alphabetical order and standardized within the three laws.

EFFECT OF PROPOSED SUBSTITUTE:

Technical changes are made to correct grammar and clarify the meaning.

Appropriation:  none

Revenue:  none

Fiscal Note:  available

TESTIMONY FOR:

This bill standardizes and alphabetizes some definitions without changing any policies.  This makes reference to those terms less confusing.  The Board of Pharmacy supports the concept.

TESTIMONY AGAINST:  None

TESTIFIED:  Steve Lindstrom, Washington State Pharmacists Association; Don Williams, Director, Board of Pharmacy, DOH